Main menu

Accelerating precision oncology research with nanopore sequencing


Whether you missed the event at the conference, or want to see the presentations again, this is a great opportunity to see Oxford Nanopore's lunchtime satellite session from AACR 2024.

Native, PCR-free nanopore sequencing, with unrestricted read lengths, offers a unique view into cancer biology. This allows the identification of single nucleotide variants, structural variants, and epigenetic modifications on a haplotype level — from a single dataset. In this symposium, we explored how these technical benefits open up a new window of understanding into cancer genomes, and featured projects ranging from cancer whole-genome sequencing to cell-free DNA with methylation, and single-cell sequencing.

Authors: Mikhail Kolmogorov, Principal Investigator, National Cancer Institute, National Institutes of Health. Ayse Keskus, Postdoctoral Fellow, National Cancer Institute, National Institutes of Health. • Julie Geyer, Postdoctoral Research Associate, University of North Carolina at Chapel Hill School of Medicine.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag